Jaraa'idJaraa'id
Notification Show More
Latest News
North Korea fires ballistic missile: Seoul
Asia
Panama warns of surge in US-bound migration through deadly jungle
Business
Carlos Alcaraz flattens Dusan Lajovic to set up last-16 clash with Tommy Paul at Miami Open
Sports
Jay Powell and Janet Yellen struggle to calm nerves in banking crisis
Business
Next Tottenham Hotspur manager: Mauricio Pochettino to return? Julian Nagelsmann or Luis Enrique?
Sports
Aa
  • Home
  • Local News
  • Africa
  • United States
  • Europe
  • Asia
  • Sports
  • Videos
  • Live Score
  • More
    • Business
    • Market Data
      • Stocks
      • Commodities
      • Cryptocurrency
      • Forex
    • Weather
Reading: Pfizer’s COVID drug data supports use in high-risk patients – FDA staff
Share
Aa
Jaraa'idJaraa'id
  • Somalia
  • Africa
  • United States
  • Europe
  • Asia
  • Business
  • Sports
  • Videos
Search
  • Home
  • Local News
  • Videos
  • World
    • Africa
    • United States
    • Europe
    • Asia
  • Market Data
    • Stocks
    • Commodities
    • Cryptocurrency
    • Forex
  • More
    • Sports
    • Business
    • Weather
    • Live Score
Have an existing account? Sign In
Follow US
Jaraa'id > United States > Pfizer’s COVID drug data supports use in high-risk patients – FDA staff
United States

Pfizer’s COVID drug data supports use in high-risk patients – FDA staff

News Room
Last updated: 2023/03/14 at 5:10 PM
News Room Published March 14, 2023
Share
SHARE

March 14 (Reuters) – The U.S. health regulator’s staff reviewers said on Tuesday data from Pfizer Inc’s (PFE.N) COVID-19 drug trials support its use in adults at high risk of progressing to severe disease.

The Food and Drug Administration made its assessment in briefing documents ahead of a meeting of the agency’s external advisers on Thursday to discuss full approval to use Pfizer’s oral pill for high-risk COVID-19 patients exhibiting mild to moderate symptoms.

The FDA’s advisers will vote on whether the benefits related to Paxlovid outweigh its risks. The agency typically follows the advice of its expert advisers, but is not mandated to do so.

Paxlovid has been authorized for emergency use since late 2021, and a full approval is likely to allow Pfizer to expand its advertising campaign for the drug.

Over 12 million courses have been delivered to pharmacies, and patients have used over 8 million courses of the treatment, according to Federal data.

There have been multiple reports on COVID rebounds in some people after taking Paxlovid. President Joe Biden and Dr Anthony Fauci, the then director of National Institute of Allergy and Infectious Diseases, both experienced a COVID rebound last year after taking the medicine.

However, during mid-to-late stage trials of the drug, overall rates of symptom rebound ranged from 10% to 16%, with no evidence of a higher rebound rate in patients who received the drug or the placebo, regardless of their risk to severe disease, or whether Omicron or an earlier variant was dominant, the reviewers said.

Paxlovid, taken for five days beginning shortly after onset of COVID symptoms, has shown reduction in risk of hospitalization or death by 86% in non-hospitalized, high-risk adult patients in Pfizer’ study, which did not include vaccinated participants.

Reporting by Leroy Leo and Khushi Mandowara in Bengaluru; Editing by Shailesh Kuber

Our Standards: The Thomson Reuters Trust Principles.

Read the full article here

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
I have read and agree to the terms & conditions
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
News Room March 14, 2023
Share this Article
Facebook Twitter Email Print
What do you think?
Love0
Sad0
Happy0
Sleepy0
Angry0
Dead0
Wink0
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular News
Asia

North Korea fires ballistic missile: Seoul

News Room News Room March 27, 2023
Panama warns of surge in US-bound migration through deadly jungle
Carlos Alcaraz flattens Dusan Lajovic to set up last-16 clash with Tommy Paul at Miami Open
Jay Powell and Janet Yellen struggle to calm nerves in banking crisis
Next Tottenham Hotspur manager: Mauricio Pochettino to return? Julian Nagelsmann or Luis Enrique?
Air India boss hails biggest turnround effort in airline’s history
Antonio Conte leaves Tottenham by mutual consent, Cristian Stellini to take charge of team for rest of season
European ammunition maker says plant expansion hit by energy-guzzling TikTok site
- Advertisement -
Ad imageAd image

You Might also Like

United States

Actor Jonathan Majors arrested in New York on assault charges

March 26, 2023
United States

US lawmaker says FBI briefed him on Trump’s rhetoric over New York probe

March 26, 2023
United States

Rep. Ro Khanna endorses Rep. Barbara Lee in Senate race in California

March 26, 2023
United States

US House speaker says lawmakers to move forward with TikTok bill

March 26, 2023
  • Somalia
  • Africa
  • United States
  • Europe
  • Asia
  • Cryptocurrency
  • Forex
  • Stock Market

About US

Jaraa'id is your one-stop website for the latest global and local news and updates, follow us now to get the news that matters to you.
Quick Link
  • Privacy Policy
  • Terms of use
  • Press ReleaseSubmit
  • Advertise
  • Contact
Top Sections
  • Business
  • Sports
  • Videos
  • Market DataLive
  • Weather

Subscribe US

Subscribe to our newsletter to get our Latest articles instantly!

I have read and agree to the terms & conditions

2023 © Jaraa'id. All Rights Reserved.

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?